-
Active Trials
-
Phase 3
-
Phase 2
-
Phase 1
-
Results Pending
📊
Pipeline Summary
Expected Approvals
FDA Decision 1 upcoming PDUFA date
HYMPAVZI (marstacimab) Hemophilia A or B (pediatric 6-11, and patients with inhibitors) sBLA
Clinical Trials
Loading...